Surgery for stubborn granulomatous breast inflammation
Part of Immune system & allergy, Women’s health & pregnancy clinical trials.
This study looks at surgical treatment for granulomatous lobular mastitis that has not been improving with non-surgical care. It may help people with more widespread or complicated breast inflammation, especially when there are abscesses or skin breakdown.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have granulomatous lobular mastitis (a specific type of breast inflammation)
- You have not had surgery for this condition yet
- Your breast involvement is more extensive (two or more breast areas) or has complications like an abscess, draining tunnel (sinus), fistula, or skin rupture
- A doctor confirmed your diagnosis as granulomatous lobular mastitis, not another clear cause by pathology (tissue testing)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different surgical methods for treating granulomatous mastitis, a rare inflammatory breast condition. It aims to find which approach works best for patients who can safely have surgery.
This study looks at a non-surgical (“conservative”) approach to treating granulomatous lobular mastitis, along with help for mental health symptoms. It may help people whose breast inflammation and mental health concerns happen together.
This trial tests a medicine called tocilizumab for a painful breast condition called granulomatous lobular mastitis that has not improved with steroids. It may help reduce inflammation and avoid surgery.
This study compares two common treatments—antibiotics versus corticosteroid pills—to see which works better for granulomatous lobular mastitis (GLM), a type of breast inflammation. Participating may help find the best way to treat your condition.
This study is creating a registry (a database) for people with a rare inflammatory breast condition called granulomatous mastitis. It aims to learn more about the disease and how it affects people, without testing any new treatments.
This trial tests a Chinese herbal medicine called Sanyong Jiedu granules for treating a breast lump caused by non-lactational mastitis (inflammation not from breastfeeding). It looks at whether the granules help reduce the lump and symptoms safely.
Hear when a new Refractory Granulomatous Lobular Mastitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.